<?xml version="1.0" ?>
<document id="190505ad74408b21fea8434a44a2f43b1ef198b7">
  <chunk id="190505ad74408b21fea8434a44a2f43b1ef198b7.c0" text="molecules A Facile Synthesis of Deaza-Analogues of the Bisindole Marine Alkaloid Topsentin">
    <entity charOffset="19-28" id="190505ad74408b21fea8434a44a2f43b1ef198b7.c0.e0" ontology_id="GO_0009058" text="Synthesis" type="gene_function"/>
  </chunk>
  <chunk id="190505ad74408b21fea8434a44a2f43b1ef198b7.c1" text="A series of substituted ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1H-indol-3-yl)-4-[(1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylates were prepared in excellent yields (82-98%) by one-pot reactions between Î²-dicarbonyl compounds 12a-e and 1,2-diaza-1,3-diene (DD) 13. Derivatives 10a,c-e, deazaanalogues of the bis-indole alkaloid topsentin, screened by the National Cancer Institute (Bethesda, MD, USA) in the in vitro one dose primary anticancer assay against a panel of about 60 human tumor cell lines, showed no significant activity, with the exception of compound 9e, which showed moderate activity against the HOP-92 cell line of the non small cell lung cancer sub-panel and the SNB-75 cell line of the CNS sub-panel.">
    <entity charOffset="393-399" id="190505ad74408b21fea8434a44a2f43b1ef198b7.c1.e0" ontology_id="HP_0002664" text="Cancer" type="phenotype"/>
    <entity charOffset="514-519" id="190505ad74408b21fea8434a44a2f43b1ef198b7.c1.e1" ontology_id="HP_0002664" text="tumor" type="phenotype"/>
    <entity charOffset="612-620" id="190505ad74408b21fea8434a44a2f43b1ef198b7.c1.e2" ontology_id="HP_0012826" text="moderate" type="phenotype"/>
    <entity charOffset="670-692" id="190505ad74408b21fea8434a44a2f43b1ef198b7.c1.e3" ontology_id="HP_0030357" text="small cell lung cancer" type="phenotype"/>
    <entity charOffset="686-692" id="190505ad74408b21fea8434a44a2f43b1ef198b7.c1.e4" ontology_id="HP_0002664" text="cancer" type="phenotype"/>
  </chunk>
</document>
